Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review.

Gala M Godoy BrewerGeorge SalemBerkeley LimketkaiFlorin M SelaruAlyssa GrossenTatiana PolicarpoZadid HaqAlyssa M Parian

Published in: Journal of clinical gastroenterology (2023)

Biologics are safe and efficacious in the treatment of chronic, refractory inflammatory conditions of the pouch. IFX seems to be more efficacious than adalimumab and vedolizumab for CARP. Further prospective, head-to-head evaluations are needed to compare biological therapies in the treatment of CARP and CD of the pouch.

Keyphrases

rheumatoid arthritis
replacement therapy
juvenile idiopathic arthritis
smoking cessation